Concepedia

Yuuichi Sugimoto

YS

Statistics

Publications

8

Citations

228

H-Index

8

Active since

2009

Affiliations

Daiichi-Sankyo (Japan)(Current)

Daiichi Sankyo (Germany)

Yuuichi Sugimoto is an author at Daiichi-Sankyo (Japan) specializing in medicinal chemistry, drug discovery, and pharmacy.

Publications per year

2009–2015

8

Publications

8

Discovery of DS-5272 as a promising candidate: A potent and orally active p53–MDM2 interaction inhibitor

Masaki Miyazaki, Masaki Miyazaki, Kouichi Uoto et al. · Bioorganic & Medicinal Chemistry · 2015 · 41 citations · Full text

, , +7

Lead optimization of novel p53-MDM2 interaction inhibitors possessing dihydroimidazothiazole scaffold

Masaki Miyazaki, Masaki Miyazaki, Hiroyuki Naito et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 35 citations · Full text

, , +11

1,3-Benzoxazole-4-carbonitrile as a novel antifungal scaffold of β-1,6-glucan synthesis inhibitors

Jun‐ichi Kuroyanagi, Kazuo Kanai, Yuuichi Sugimoto et al. · Bioorganic & Medicinal Chemistry · 2010 · 34 citations

, , +13

Synthesis and evaluation of novel orally active p53–MDM2 interaction inhibitors

Masaki Miyazaki, Masaki Miyazaki, Hiroyuki Naito et al. · Bioorganic & Medicinal Chemistry · 2013 · 34 citations

, , +8

Discovery of <i>trans</i>-4-[1-[[2,5-Dichloro-4-(1-methyl-3-indolylcarboxamido)phenyl]acetyl]-(4<i>S</i>)-methoxy-(2<i>S</i>)-pyrrolidinylmethoxy]cyclohexanecarboxylic Acid: An Orally Active, Selective Very Late Antigen-4 Antagonist

Fumihito Muro, Shin Iimura, Yuuichi Sugimoto et al. · Journal of Medicinal Chemistry · 2009 · 25 citations · Full text

, , +14

1–5 of 8